USPTO serial 79197836
RENALTX-SCORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- TRUSILO, KELLY JEAN
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RENALTX-SCORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical or veterinary purposes; reagents for use in medical analysis; diagnostic reagents in kit form for medical purposes | ACTIVE | — |
| 009 | Computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; machine readable data carriers, namely, prerecorded magnetic or optical data carriers featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements | ACTIVE | — |
| 042 | Development, programming and implementation of analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, software for the operation of spectrometers, and software for evaluating the results of spectroscopic investigations and measurements; scientific and technological services, scientific and biotechnological testing services as well as medical and pharmacological research services in the fields of spectroscopy, of analyses of body fluids or their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical and scientific laboratory services for analytical tests; working on and evaluation of chemical analyses; consultancy and providing information for the aforesaid services, included in this class | ACTIVE | — |
| 044 | Medical services in the field of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia or diabetes; medical laboratory services for the analysis of samples taken from patients; medical analysis services for diagnosis and prognosis of diseases; consultancy and providing information for the aforesaid services, included in this class | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2018 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 30, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 28, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 28, 2017 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 28, 2017 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 21, 2017 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 17, 2017 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 3, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 30, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 30, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 29, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 28, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 8, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |